Skip to content

Daniel Shortt

Corporate & Regulatory Attorney

Email Daniel

Daniel is a corporate and regulatory attorney based in Seattle, Washington who works extensively with entrepreneurs in the cannabis industry. He advises clients on matters related to both hemp and marijuana, and frequently speaks on legal issues relating to cannabis across the country and abroad. Daniel is quoted as an authority on cannabis law in dozens of publications including Marijuana Moment, Hemp Industry Daily, the Washington Post, and Bloomberg, to name a few. Before joining Green Light Law Group, Daniel spent five years at Harris Bricken and wrote for the Canna Law Blog.

Daniel graduated from the University of Washington School of Law, where he worked extensively with the Washington State Liquor and Cannabis Board to fund and establish the Cannabis Law and Policy Project (CLPP). He then served as the editor of the CLPP blog and as a Hazelton Fellow researching cannabis law. Daniel also interned for Justice Richard Baldwin of the Oregon Supreme Court and for the Seattle City Attorney.

As an undergrad, Daniel studied music at Gonzaga University, focusing on jazz guitar. After college, he worked and volunteered at the Boys and Girls Club. In his spare time, Daniel enjoys playing guitar, taking boxing classes, and exploring Seattle with his wife Ciera and their two dogs Dexter and Oliver.

Professional Activities
Washington State Bar Association’s Cannabis Law Section – Executive Board Member (2018 - 2022)

Professional Recognitions
SuperLawyers Rising Star Honoree (2022)

Admissions
Washington

Daniel Shortt

Speaking Engagements

Selling Hemp Derived CBD Products in Your Retail Shop, Why Now ASD Market Week, June 9, 2020.

Media Appearances

Daniel's Blog Posts

Team work
Article

Washington Cannabis Social Equity FAQs

After ten years of cannabis legalization, Washington is poised to establish a social equity cannabis program. Social equity applicants who…

Targeting Letters Low res
Article

The FDA is Quietly Targeting CBD in 2022

The Food and Drug Administration (FDA) has consistently taken the position that cannabidiol derived from hemp (CBD) cannot be marketed…

Adobe Stock 427550610
Article

How Would the Cannabis Administration and Opportunity Act Work?

A few weeks ago, Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory…

Megaphone advertising
Article

New York Proposes Adult-Use Cannabis Advertising Rules

New York’s Office of Cannabis Management (OCM) recently proposed Adult-Use Advertising Rules. The proposed rules were published in the New…